Page 3 - Rushmie Nofsinger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders

Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomRushmie nofsingerMolly macleodJay backstromMo qatananiExchange commissionHead of researchScholar rock incChief executive officerScholar rockSenior vice presidentPrivate securities litigation reform actQuarterly report

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomRushmie nofsingerExchange commissionScholar rock incEquity planScholar rockNasdaq listing ruleStock option awardSecurities act

Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress

Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomTed mylesJay backstromRushmie nofsingerExchange commissionScholar rock incOncology programScholar rock holding corporationChief executive officerCompany highlightsMuscular atrophyClinical care meetingScholar rockChief operating officerChief financial officerSecurities act

New 36-Month Apitegromab Extension Data Reinforce Long-Term Substantial and Sustained Improvement of Motor Function in Phase 2 TOPAZ Trial Patients with Nonambulatory Spinal Muscular Atrophy

New 36-Month Apitegromab Extension Data Reinforce Long-Term Substantial and Sustained Improvement of Motor Function in Phase 2 TOPAZ Trial Patients with Nonambulatory Spinal Muscular Atrophy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesRushmie nofsingerTeagan whiteDisney swanThomas crawfordJay backstromThomaso crawfordResearch clinical care meetingDolphin hotelsResearch clinical care meeting in orlandoDrug administrationScholar rock incExchange commissionEuropean medicines agencyJohns hopkins university

Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors

CAMBRIDGE, Mass. (BUSINESS WIRE) Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that Richard Brudnick, has been appointed to Scholar Rock’s Board of Directors as an.

United kingdomRichard brudnickTamarix pharmaCodiak biosciencesRushmie nofsingerDavid hallalTeagan whiteExchange commissionAlliance management at bioverativScholar rock incBusiness developmentScholar rockChief business officerPrime medicineExecutive vice presidentAlliance management